Start an analysis for SBC
SBC Medical Group Holdings Incorporated
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $20m | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Remaining authorization | $20mEST | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Program expiry | 31-Dec-26 | 30-Sep-26 | 10-Q filed 13-Nov-26 |
| Repurchased last quarter | Not found in filings | — | |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 29-Dec-25 | $20m | $20mEST | 31-Dec-26 | On December 29, 2025, the Company’s board of directors authorized a share repurchase program of up to $20.0 million, pursuant to which the Company may repurchase shares of its common stock from time to time. The program terminates on December 31, 2026.10-Q filed 13-Nov-26 |
Open-market repurchases
None reported in the filings we hold.